AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of $326.55 billion. The enterprise value is $389.02 billion.
Important Dates
The last earnings date was Friday, April 25, 2025, before market open.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | Apr 15, 2025 |
Share Statistics
AbbVie has 1.77 billion shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 1.77B |
| Shares Outstanding | 1.77B |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 0.08% |
| Owned by Institutions (%) | 73.43% |
| Float | 1.77B |
Valuation Ratios
The trailing PE ratio is 78.89 and the forward PE ratio is 14.49. AbbVie's PEG ratio is 1.12.
| PE Ratio | 78.89 |
| Forward PE | 14.49 |
| PS Ratio | 5.69 |
| Forward PS | 5.25 |
| PB Ratio | 98.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.12 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 93.63 |
| EV / Sales | 6.78 |
| EV / EBITDA | 14.26 |
| EV / EBIT | 20.62 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 20.22 |
| Debt / EBITDA | 2.46 |
| Debt / FCF | n/a |
| Interest Coverage | 6.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.33% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $1.04M |
| Profits Per Employee | $75,545 |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -581.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.05% in the last 52 weeks. The beta is 0.55, so AbbVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +15.05% |
| 50-Day Moving Average | 196.32 |
| 200-Day Moving Average | 189.28 |
| Relative Strength Index (RSI) | 45.10 |
| Average Volume (20 Days) | 7,866,772 |
Short Selling Information
The latest short interest is 16.84 million, so 0.95% of the outstanding shares have been sold short.
| Short Interest | 16.84M |
| Short Previous Month | 19.70M |
| Short % of Shares Out | 0.95% |
| Short % of Float | 0.95% |
| Short Ratio (days to cover) | 1.80 |
Income Statement
In the last 12 months, AbbVie had revenue of $57.37 billion and earned $4.16 billion in profits. Earnings per share was $2.34.
| Revenue | 57.37B |
| Gross Profit | 40.69B |
| Operating Income | 18.86B |
| Pretax Income | n/a |
| Net Income | 4.16B |
| EBITDA | 27.27B |
| EBIT | 18.86B |
| Earnings Per Share (EPS) | $2.34 |
Full Income StatementBalance Sheet
The company has $5.56 billion in cash and $68.02 billion in debt, giving a net cash position of -$62.46 billion or -$35.31 per share.
| Cash & Cash Equivalents | 5.56B |
| Total Debt | 68.02B |
| Net Cash | -62.46B |
| Net Cash Per Share | -$35.31 |
| Equity (Book Value) | 3.36B |
| Book Value Per Share | 1.88 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 70.93%, with operating and profit margins of 32.88% and 7.31%.
| Gross Margin | 70.93% |
| Operating Margin | 32.88% |
| Pretax Margin | 6.31% |
| Profit Margin | 7.31% |
| EBITDA Margin | 47.54% |
| EBIT Margin | 32.88% |
| FCF Margin | n/a |